About Esketamine Hydrochloride
            
            Class: | NMDA receptor antagonist, antidepressant  
Use: | Treatment-resistant depression (TRD) in adults, and depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior  
Adult dose: | Initial dose of 56 mg administered as a nasal spray, may be increased to 84 mg based on clinical response; typically administered twice a week for the first four weeks, followed by a maintenance phase  
Pediatric dose: | Safety and efficacy not established in pedia
         
        
            
                
                
                    
                        Drug Class
                    
                    NMDA receptor antagonist, antidepressant
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment-resistant depression (TRD) in adults, and depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the original carton at 20°C to 25°C (68°F to 77°F); protect from light; do not freeze
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Janssen Cilag International N.V., BELGIUM
                    
                    
                    Package Size
                    Device X 1
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1238.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 56 mg administered as a nasal spray, may be increased to 84 mg based on clinical response; typically administered twice a week for the first four weeks, followed by a maintenance phase
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Dissociation, dizziness, nausea, headache, sedation, increased blood pressure, vomiting
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to esketamine or any component of the formulation; history of aneurysmal vascular disease or arteriovenous malformation; concurrent use of monoamine oxidase inhibitors (MAOIs)
         
        
        
            
                Important Warnings
            
            Risk of sedation and dissociation; potential for abuse and misuse; monitor blood pressure before, during, and after administration; not for use in patients with a history of substance use disorder; may cause suicidal thoughts or behaviors in some patients
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.